Investigation of Synergistic Effects of Curcumin with Some Antibiotics in Extended Spectrum Beta Lactamase Positive Or Negative Escherichia Coli and Klebsiella Pneumoniae Isolates

Basit Öğe Kaydı
dc.contributor.authorGüneş, Hayati
dc.contributor.authorDoğan, Mustafa
dc.contributor.authorGümüş, Abdullah
dc.contributor.authorMutlu, Reyhan
dc.contributor.authorTopkaya, Aynur Eren
dc.date.accessioned2022-05-11T14:12:37Z
dc.date.available2022-05-11T14:12:37Z
dc.date.issued2013
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Mikrobiyoloji Ana Bilim Dalı
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları Ana Bilim Dalı
dc.description.abstractIntroduction: In recent years resistance against some antibiotics, particularly carbapenems, one of the first options for treatment, has increased among extended spectrum beta lactamase (ESBL) producing E. coli and K. pneumoniae isolates. In this study. the influence of curcumin on amikacin, gentamycin, imipenem and ciprofloxacine minimum inhibitory concentration (MIC) values of ESBL positive and negative E. coli or K. pneumoniae isolates, was investigated. Methods: For this purpose, a total of 63 Escherichia coli (30 ESBL + and 33 ESBL -) and 22 K. pneumoniae isolates (10 ESBL + and 12 ESBL -) were included in the study. MIC values of bacteria were determined with microdilution method according to Clinical and Laboratory Standards Institute (CLSI) recommendations. Synergistic effect of curcumin was studied with checkerboard method. Results: In both bacteria groups, ESBL + isolates were found to be more resistant against all tested antibiotics compared to ESBL - ones. Curcumin was detected not to have a synergistic effect with amikacin, gentamycin and ciprofloxacin in low and high concentrations. Curcumin/imipenem combination was determined to reduce MIC values of imipenem in all ESBL + and ESBL - E. coli and K. pneumoniae isolates resistant to imipenem and brought MIC values to susceptible limits. Conclusion: In conclusion, curcumin may be combined with carbapenems in severe infections caused by ESBL + E. coli and K. pneumoniae isolates, as its bioavailability is good and well tolerated in therapeutic concentrations.
dc.identifier.endpage765
dc.identifier.issn0393-6384
dc.identifier.issn2283-9720
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-84896705736
dc.identifier.scopusqualityN/A
dc.identifier.startpage761
dc.identifier.urihttps://hdl.handle.net/20.500.11776/5618
dc.identifier.volume29
dc.identifier.wosWOS:000330151200027
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorGüneş, Hayati
dc.institutionauthorDoğan, Mustafa
dc.institutionauthorGümüş, Abdullah
dc.institutionauthorMutlu, Reyhan
dc.institutionauthorTopkaya, Aynur Eren
dc.language.isoen
dc.publisherCarbone Editore
dc.relation.ispartofActa Medica Mediterranea
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectExtended spectrum beta lactamase
dc.subjectE. coli
dc.subjectK. pneumoniae
dc.subjectcurcumin
dc.subjectimipenem
dc.subjectCombination
dc.subjectResistance
dc.subjectInfection
dc.subjectStrains
dc.titleInvestigation of Synergistic Effects of Curcumin with Some Antibiotics in Extended Spectrum Beta Lactamase Positive Or Negative Escherichia Coli and Klebsiella Pneumoniae Isolates
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
5618.pdf
Boyut:
119.92 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu